Actinium Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q3 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Actinium Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q3 2023 to Q1 2024.
  • Actinium Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending March 31, 2024 was $165K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $165K Mar 31, 2024 10-Q 2024-04-26
Q3 2023 $188K Sep 30, 2023 10-K 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.